Recombinant soluble CD14 inhibits LPS-induced mortality in a murine model.
Department of Medicine, North Shore University Hospital/Cornell University Medical College, Manhasset, New York 11030, USA.
S M
SM
Goyert
A
A
Haziot
D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D066298:In Vitro Techniques; D018950:Lipopolysaccharide Receptors / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors* / Q000633:toxicity; D051379:Mice; D011994:Recombinant Proteins / Q000494:pharmacology; D012772:Shock, Septic / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D012995:Solubility; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha